Malaria vaccine: Report describes complete protection after 10 weeks with three doses
by Press Release from Outbreak News Today on (#2CWZC)
In a report published Wednesday in Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine) investigators from the University of Ti1/4bingen reported all nine subjects (100%) immunized with three doses of Sanaria(R) PfSPZ-CVac malaria vaccine in a recently completed clinical trial were protected against Plasmodium falciparum malaria when exposed to the disease 10 weeks after ["]
The post Malaria vaccine: Report describes complete protection after 10 weeks with three doses appeared first on Outbreak News Today.